Industries > Pharma > Medical Device Leader Series: Top Needle-Free Injection Device Developers, Manufacturers and Marketers in 2016

Medical Device Leader Series: Top Needle-Free Injection Device Developers, Manufacturers and Marketers in 2016

Market Analysis Including Antares Pharma, PharmaJet, Mylan and Other Firms in North America, Europe, Israel and Asia Pacific, Covering Jet Injectors, Transdermal Patches, Microneedles, Pen Injectors and Other Drug Delivery Systems

PUBLISHED: 13 June 2016
PAGES: 174
PRODUCT CODE: PHA0122
SUBMARKET: Medical Devices

Clear
WOOCS 2.2.1
SKU: PHA0122 Categories: ,

Needle-Free Drug Injecting Technologies – Discover Leading Companies’ Products, Developments, Results and Potentials
What does the future hold for producers of needle-free injection (NFI) products? Visiongain’s updated, expanded report shows you data to 2026 for that industry and market. There you find analysis, trends, opportunities, prospects and revenue forecasting. Don’t miss out.

Our new study analyses 28 leading developers and producers of those medical devices. NFI drug delivery holds great potential from 2016 for the therapeutic and commercial advancement of biologics and vaccines. Discover what that progress means and how you can benefit your work and influence.

So read on, please, to scan that industry’s leading participants and see what its future market could be worth.

Medical Device Leader Series: Top Needle-Free Injection Device Developers, Manufacturers and Marketers in 2016

Results and forecasting to help you stay ahead in knowledge on those medical injectors
With our study you examine the industry for needleless injection and needle-free syringes – insulin injectors and other systems. Explore that industry’s progress. See the potential for novel and improved subcutaneous, intradermal, intramuscular and intravenous drug delivery.

That market advances fast. In our report you assess product ranges, historical data, R&D, sales prediction and financial results. There you gain quantitative and qualitative analyses. In our 173 page report you find 74 tables, 9 charts and an interview with a prominent company.

NFI technology – discover how to benefit your work, also finding where the money lies
In our analysis you see how developers overcome problems with parenteral drug application, especially benefiting the use of biological drugs. You also discover potential revenues.

The following sections explain how our new investigation can benefit your work.

Companies based in North America – what are their outlooks?
First our study gives you financial data and discussions for prominent North American NFI developers and manufacturers:
• Antares Pharma
• Bioject Medical Technologies
• Activa Brand Products
• D’Antonio Consultants International
• National Medical Products
• Medical International Technologies
• Penjet Corporation
• PharmaJet
• Valeritas
• 3M
• Zogenix
• Mylan
• Becton, Dickinson and Company
• Portal Instruments.

Discover what the present and future hold for leading companies. Also see revenue predictions to 2026 for the overall world industry for needle-free injection devices.

Also hear about developments and prospects of firms in other countries.

Europe – outlooks for leading developers and producers of medical injection technology
Next our report analyses European-based specialists in that drug delivery:
• Akra Dermojet
• Crossject Medical Technology
• Glide Pharma
• Merck KGaA
• Spirit Healthcare
• AstraZeneca.

Many commercial opportunities exist, with expanding revenues possible from 2016 to 2026. Explore companies well placed to succeed. That way you see how organisations gain advantages, develop technologies and increase revenues.

Companies in other regions – developed and developing countries’ technologies
How do companies in India, China, South Korea, Singapore, Israel and Australia contribute? Our report shows activities, results and outlooks of these organisations:
• Injex Pharma AG
• Romsons Scientific & Surgical
• Binny’s Health Care
• Mika Medical Co.
• JMS Singapore
• B. Braun Singapore
• NanoPass Technology
• Vaxxas.

With our survey you discover progress, potentials and R&D across the world, assessing what is possible from 2016. Stay ahead in knowledge to help your work.

Events and forces affecting developers, producers and sellers of NFI technologies
Our study explains issues affecting that industry and market from 2016, including these influences:
• Jet injector devices, transdermal patches, microneedles, pen injectors and other systems
• Applications – pain management, vaccine delivery, treating diabetes, paediatric medicine and other uses, including self-administration and home-based therapy
• Regulations affecting that medical equipment industry – challenges and opportunities
• Solid formulations and other issues, innovations and developments
• Deals, collaborations and other changes affecting those technology providers.

There you explore political, economic, social and technological questions, investigating outlooks for business. Examine what stimulates and restrains that industry and market.

Our study forecasts that overall worldwide sales of needle-free injection devices will reach $1.98 billion in 2020, with strong sales growth to 2026. With that analysis you explore how those companies, progress, compete and succeed. Avoid missing out on data.

You also read opinions from a company we interviewed. See what that industry’s present and future hold, assessing opportunities for companies to contribute, expand and benefit.

Six main ways Top Needle-Free Injection Device Developers, Manufacturers and Marketers in 2016 helps your work
Our report gives the following knowledge to benefit your research, analyses, plans, decisions and presentations:
• Analysis of 28 companies’ needle-free injection products and technologies
• Investigation of firms’ research and development
• Coverage of organisations’ strengths, weaknesses, activities, outlooks and prospects
• Revenue forecasting and discussions for that industry from 2016 to 2026
• Comments from the CEO of a leading company, revealing insight in our interview
• Assessment – SWOT and STEP analyses – of the needle-free injection devices market, appraising that industry’s present and future.

That investigation, by Visiongain’s in-house team in the UK, has the purpose of helping everyone interested in the future of needle-free injections and related drugs, instruments, containers and accessories. Discover analysis leading organisations depend on.

Analysis found nowhere else – explore the future of that medical device technology
With our research and analysis you are less likely to fall behind in knowledge or miss opportunity. There see how you could save time and effort. That way you could benefit your plans, decisions and presentations, helping you gain advantages and recognition.

Trying our study now lets you discover the latest progress and opportunities
Our new research is for everyone analysing drug delivery and pharmaceutical R&D. For leading companies and technologies you explore trends, progress and opportunities. So avoid missing out – please get our new report here now.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for Medical Device Leader Series: Top Needle-Free Injection Device Developers, Manufacturers and Marketers in 2016


Download sample pages

Complete the form below to download your free sample pages for Medical Device Leader Series: Top Needle-Free Injection Device Developers, Manufacturers and Marketers in 2016


Latest Pharma news

Visiongain Publishes Cancer Diagnostics Market Report 2021-2031

Major investments have been made by companies in the cancer diagnostics industry in the past few years to develop novel tests to capitalize on the opportunities in the untapped market.

19 April 2021

READ

Visiongain Publishes Food for Special Medical Purpose (FSMP) Market Report 2020-2030

The food for special medical purpose (FSMP) market growth can be attributed to the growing prevalence of metabolic diseases, growing consumer unhealthy lifestyle, and surge in demand from emerging economies such as Asia Pacific, Middle East & Africa, Latin America, and others.

12 April 2021

READ

Visiongain Publishes Cell-Based Assays Market Report to 2030

Growing incidence of chronic diseases; increasing R&D investment for drug discovery research and Growing Adoption of High-Throughput Screening Methodologies are some of the major factors that propel the market growth.

09 April 2021

READ

Visiongain Publishes Cancer Biologics Therapies Market Report 2021-2031

The main drivers for the growth include technological advancements in the development of novel biomarkers, rising preference for minimally or less invasive surgeries, increasing cancer awareness leading to growth in cancer cases, and growing disposable income in emerging economies.

06 April 2021

READ

Categories